Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects

Status:
Completed

Trial end date:
2004-08-01

Target enrollment:

Participant gender:

To assess safety and toleration, systemic exposure and anti-scarring potential of intradermal avotermin (Juvista) in young females.

Phase 1/Phase 2

Renovo